mTOR Pathway Biomarkers in Upper Tract Urothelial Carcinoma

SUO 2013 - Evaluation of the Prognostic Significance of Altered Mammalian Target of Rapamycin (MTOR) Pathway Biomarkers in Upper Tract Urothelial Carcinoma

Click HERE to read session highlights from the meeting, reported by the Fox Chase Cancer Center team.

E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe